US House of Reps Passes FDA Reform Act
Just days after the US Senate overwhelming approved the Food and Drug Administration Safety and Innovation Act (FDASIA), which included reauthorization of the Prescription Drug User Fee Act (PDUFA; The Pharma Letter May 28), the House of Representati..
Original Article: US House of Reps Passes FDA Reform Act
NEXT ARTICLE